Franck Mouthon created Theranexus with Mathieu Charvériat in 2013. He has been serving as Chief Executive Officer and Chairman since the company was founded. He is currently the President of France Biotech, an independent association that brings together HealthTech entrepreneurs and their expert partners. Before Theranexus, Franck was head of a research group focused on neurological disorders within the French Alternative Energies and Atomic Energy Commission (CEA). A neuroscientist by training, Franck Mouthon graduated from Ecole Normale Supérieure de Paris.